Invenomic Capital Management’s Civeo CVEO Stock Holding History

Invenomic Capital Management’s Portfolio CVEO Stock Details CVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,458	Closed	-$549K	–	169
2024 Q1	$549K	Sell	20,458 -358	-2%	-$8.32K	0.03%	143
2023 Q4	$476K	Sell	20,816 -15,966	-43%	-$345K	0.02%	171
2023 Q3	$762K	Sell	36,782 -1,256	-3%	-$24.4K	0.03%	144
2023 Q2	$741K	Buy	+38,038	New	+$767K	0.04%	132
2022 Q3	–	Sell	-42,000	Closed	-$1.09M	–	158
2022 Q2	$1.09M	Sell	42,000 -58,412	-58%	-$1.57M	0.08%	135
2022 Q1	$1.94M	Buy	100,412 +4,691	+5%	+$104K	0.21%	99
2021 Q4	$1.83M	Buy	95,721 +1,908	+2%	+$40.8K	0.39%	77
2021 Q3	$2.11M	Sell	93,813 -73,813	-44%	-$1.6M	0.68%	50
2021 Q2	$2.98M	Buy	167,626 +38,167	+29%	+$639K	0.71%	31
2021 Q1	$1.98M	Buy	+129,459	New	+$2.24M	0.44%	45

Other funds holding CVEO

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Invenomic Capital Management's CVEO Position: Q2 2024 in Review

Invenomic Capital Management sold out of Civeo (CVEO) in Q2 2024, closing a stake of 20,458 shares — an estimated $549K sold.

Invenomic Capital Management first reported a position in CVEO in Q1 2021 and held it in 10 quarters. The position peaked at $2.98M in Q2 2021. 73 funds tracked by Wall St. Rank hold CVEO as of Q2 2024.

Invenomic Capital Management reported no remaining Civeo position as of Q2 2024 after selling out during the quarter.
Invenomic Capital Management sold 20,458 Civeo shares in Q2 2024, an estimated $549K.
Invenomic Capital Management first reported a position in Civeo in Q1 2021 and held it in 10 quarters.
Invenomic Capital Management's Civeo position peaked at $2.98M in Q2 2021.
73 funds tracked by Wall St. Rank held Civeo as of Q2 2024.

Based on Invenomic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.